Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I).
Simon BernatzInes BöthJörg AckermannIris BurckScherwin MahmoudiLukas LengaSimon S MartinJan-Erik ScholtzVitali KochLeon D GrünewaldIna KochTimo StöverPeter J WildRia WinkelmannThomas J VoglDaniel Pinto Dos SantosPublished in: BMC medical imaging (2023)
EN and RSF built on radiomics features may be used for survival prognostication. The prognostically leading features may vary between treatment subgroups. This warrants further validation to potentially aid clinical treatment decision making in the future.